Published in Proc Natl Acad Sci U S A on May 14, 1996
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci U S A (1997) 1.23
The retinoblastoma family: twins or distant cousins? Genome Biol (2002) 1.02
Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143. Nucleic Acids Res (2007) 0.96
Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol (2002) 0.78
Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer. PLoS One (2015) 0.78
pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. BMC Clin Pathol (2009) 0.76
Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer. Mol Pathol (2002) 0.75
Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem (1981) 49.46
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev (1988) 7.52
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell (1993) 6.24
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev (1993) 5.32
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 4.69
Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell (1991) 3.47
Regulation of translation in eukaryotic systems. Annu Rev Cell Biol (1992) 3.46
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci (1994) 3.32
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev (1995) 3.02
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev (1995) 2.33
E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol (1995) 2.26
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene (1989) 2.09
Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene (1993) 1.99
The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci U S A (1992) 1.94
Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene (1991) 1.84
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol (1995) 1.61
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr (1995) 1.58
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res (1994) 1.46
Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A (1989) 1.44
Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev (1990) 1.42
Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box. J Biol Chem (1989) 1.42
Genomic organization of the human retinoblastoma gene. Oncogene (1989) 1.04
The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene (1993) 1.02
Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene (1995) 0.92
The RB2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem (1995) 0.86
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (1992) 6.40
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
RB and cell cycle progression. Oncogene (2006) 3.77
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med (1996) 3.44
Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem (1996) 3.05
Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell (2001) 2.69
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst (1998) 2.32
PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A (1994) 2.29
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 2.24
Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ (1996) 2.18
Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. Eur Heart J (1999) 2.12
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res (1997) 2.05
p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J (1997) 2.05
Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med (1997) 2.01
Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene (1993) 1.99
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene (2007) 1.97
Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation (1997) 1.97
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect (2012) 1.92
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet (1992) 1.81
Determinants of survival in progressive multifocal leukoencephalopathy. Neurology (2009) 1.77
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. Mult Scler (2010) 1.74
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest (1998) 1.73
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med (1997) 1.69
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area. Circulation (1994) 1.68
Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem (1996) 1.67
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology (2011) 1.65
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med (2011) 1.64
The magnetic field of an isolated neutron star from X-ray cyclotron absorption lines. Nature (2003) 1.63
Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene (2006) 1.60
The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr (1995) 1.58
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis (1999) 1.56
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.55
Fatigue effects on body balance. Electroencephalogr Clin Neurophysiol (1997) 1.53
Steal phenomenon from mammary side branches: when does it occur? Ann Thorac Surg (1998) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Special factors in biological strings. J Theor Biol (2000) 1.51
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res (1998) 1.51
Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst (1998) 1.48
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS (1995) 1.47
Cell cycle and apoptosis. Neoplasia (2001) 1.47
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res (1994) 1.46
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res (2000) 1.45
Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol (1996) 1.45
The role of EGF-related peptides in tumor growth. Front Biosci (2001) 1.45
Current management of esophageal foreign bodies. Arch Otolaryngol (1981) 1.44
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43
Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment. J Neurol Neurosurg Psychiatry (2001) 1.40
Changed epidemiology of ICU acquired bloodstream infections over 12 years in an Italian teaching hospital. Minerva Anestesiol (2014) 1.40
Assessment of oxygen uptake during the six-minute walk test in patients with heart failure. Chest (1997) 1.39
Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am Heart J (1999) 1.39
Considerations about the use and misuse of Rasch analysis in rehabilitation outcome studies. Eur J Phys Rehabil Med (2009) 1.38
Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology (1999) 1.38
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation (1997) 1.38
Responses of leg muscles in humans displaced while standing. Effects of types of perturbation and of postural set. Brain (1990) 1.37
Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J Anat (2008) 1.36
Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Colorectal Dis (2012) 1.32
Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr (2000) 1.31
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology (1997) 1.31
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis. Ann Oncol (2009) 1.30
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol (1993) 1.29
Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene (2006) 1.29
CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc Natl Acad Sci U S A (1996) 1.28
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Is there a specific visuo-spatial impairment in Parkinsonians? J Neurol Neurosurg Psychiatry (1986) 1.28
PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol (1996) 1.27
AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res (1997) 1.25
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol Pharmacol (2000) 1.24
Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene (1993) 1.23
The adipose organ: white-brown adipocyte plasticity and metabolic inflammation. Obes Rev (2012) 1.22
Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res (2000) 1.22
Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy. J Clin Microbiol (1984) 1.21
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect (2011) 1.21
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol (2009) 1.20
Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene (1999) 1.20
Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res (2001) 1.19
Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1994) 1.19
Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem (1996) 1.19
The retinoblastoma gene is involved in multiple aspects of stem cell biology. Oncogene (2006) 1.19
The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res (1998) 1.18
Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol (2006) 1.18
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB). J Gen Physiol (2001) 1.18
Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr (2001) 1.18
Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest (1998) 1.17
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol (1998) 1.16